Merit Medical Systems (MMSI) vs Insulet (PODD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Merit Medical Systems (MMSI) has outperformed Insulet (PODD) over the past year, gaining 2.9% versus a loss of 57.1%. Over five years, MMSI leads with a +22.3% price change compared with -55.3% for PODD. Insulet is the larger company by market cap ($9.32 billion vs $5.08 billion), about 1.8 times the size.
On valuation, Insulet trades at a lower forward P/E (17.4x vs 18.5x for Merit Medical Systems). Insulet converts more of its revenue into profit, with a net margin of 9.1% versus 8.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMSI | PODD |
|---|---|---|
| Share price | $85.09 | $134.36 |
| Market cap | $5.08B | $9.32B |
| 1-day change | +0.15% | -0.27% |
| YTD return | -3.46% | -52.73% |
| 1-year return | +2.89% | -57.14% |
| 5-year return | +22.27% | -55.29% |
| P/E ratio (TTM) | 35.02 | 25.16 |
| Forward P/E | 18.45 | 17.38 |
| EPS (TTM) | $2.43 | $5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.52B | $2.71B |
| Revenue growth (YoY) | +11.75% | +30.73% |
| Net income (latest FY) | $128.49M | $247.10M |
| Gross margin | 48.70% | 71.63% |
| Operating margin | 12.19% | 17.50% |
| Net margin | 8.48% | 9.12% |
| 52-week high | $94.75 | $354.88 |
| 52-week low | $59.74 | $126.40 |
| Distance from 52-week high | -10.20% | -62.14% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +19.23% | +27.24% |
| Average volume | 800.76K | 1.69M |
| Shares outstanding | 59.71M | 69.35M |
| Employees | 7,500 | 5,400 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MMSI has outperformed PODD by 60.0 percentage points over the past year.
- Merit Medical Systems trades at a higher earnings multiple (35.0x vs 25.2x trailing P/E).
- Insulet grew revenue faster in its latest fiscal year (+30.73% vs +11.75%).
About Merit Medical Systems
MMSI stock →Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Health Care · Medical/Dental Instruments · 7,500 employees
About Insulet
PODD stock →Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System.
Health Care · Medical/Dental Instruments · 5,400 employees
MMSI vs PODD FAQ
Which is bigger, Merit Medical Systems or Insulet?
Insulet (PODD) is larger, with a market capitalization of $9.32B compared with $5.08B for Merit Medical Systems (MMSI).
Which stock has performed better over the past year, MMSI or PODD?
MMSI returned +2.89% over the past 12 months, compared with -57.14% for PODD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MMSI or PODD?
PODD has the lower trailing P/E at 25.2, versus 35.0 for MMSI. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Merit Medical Systems and Insulet in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.